A Bioactuator-Driven Ankle Dorsiflexor Unit

Information

  • Research Project
  • 7050658
  • ApplicationId
    7050658
  • Core Project Number
    R43HD052313
  • Full Project Number
    1R43HD052313-01
  • Serial Number
    52313
  • FOA Number
  • Sub Project Id
  • Project Start Date
    4/3/2006 - 20 years ago
  • Project End Date
    3/31/2007 - 19 years ago
  • Program Officer Name
    QUATRANO, LOUIS A
  • Budget Start Date
    4/3/2006 - 20 years ago
  • Budget End Date
    3/31/2007 - 19 years ago
  • Fiscal Year
    2006
  • Support Year
    1
  • Suffix
  • Award Notice Date
    4/3/2006 - 20 years ago
Organizations

A Bioactuator-Driven Ankle Dorsiflexor Unit

[unreadable] DESCRIPTION (provided by applicant): A significant number of individuals in the U.S. are affected by diseases and injuries that give rise to a troublesome condition called foot drop. Diabetes mellitus, dysvascular diseases, peripheral neuropathies, and other conditions render some individuals unable to lift their foot effectively during their gait cycle, leaving them susceptible to falling or injury. Currently, ankle-foot orthoses (AFOs) are commonly used to orient the foot more favorably for ambulation, and functional electrical stimulation techniques are also being tried with some success. For some individuals, however, these approaches are not suitable or involve unacceptable medical risks. An attractive solution is an externally worn, easily donned system that restores coordinated powered ankle dorsiflexion in time with the wearer's natural gait cycle. In this three phase research program, ADA will leverage previous successful research with electroactive polymer actuators to develop such an ankle dorsiflexion system. Through earlier research funded by the NIH, ADA has demonstrated that its modular bioactuator technology-effectively prosthetic muscles-can power full-scale human upper-limb prosthetic appliances. The natural extension of this work to address the problem of foot drop was originally suggested by ADA'S network of supporting clinicians with the concurrence of the NIH's technical reviewers. In Phase I, ADA will demonstrate the technical feasibility of using electroactive polymer actuators to dorsiflex a simulated human ankle. Phase II will encompass the development of a complete functional system and clinical performance validations using human volunteer subjects. Commercialization will follow in Phase III, with the release of an ankle dorsiflexor product clinicians can prescribe for patients affected by foot drop. [unreadable] [unreadable]

IC Name
EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT
  • Activity
    R43
  • Administering IC
    HD
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    124415
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    865
  • Ed Inst. Type
  • Funding ICs
    NICHD:124415\
  • Funding Mechanism
  • Study Section
    MRS
  • Study Section Name
    Musculoskeletal Rehabilitation Sciences Study Section
  • Organization Name
    ADA TECHNOLOGIES, INC.
  • Organization Department
  • Organization DUNS
    148034408
  • Organization City
    LITTLETON
  • Organization State
    CO
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    80127
  • Organization District
    UNITED STATES